These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21689211)

  • 1. The burden of HCV treatment in patients with inherited bleeding disorders.
    Fransen van de Putte DE; Fischer K; Posthouwer D; Mauser-Bunschoten EP
    Haemophilia; 2011 Sep; 17(5):791-9. PubMed ID: 21689211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence, course and risk factors of depression during antiviral treatment for chronic hepatitis C in patients with inherited bleeding disorders: a prospective study.
    Fransen Van De Putte DE; Fischer K; Posthouwer D; Van Erpecum K; Mauser-Bunschoten EP
    Haemophilia; 2009 Mar; 15(2):544-51. PubMed ID: 19175422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The adherence in the treatment of chronic hepatitis C].
    Pawłowska M; Halota W
    Pol Merkur Lekarski; 2005 Apr; 18(106):469-72. PubMed ID: 16161937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects.
    Marcellin F; Préau M; Dellamonica P; Ravaux I; Kurkdji P; Protopopescu C; Carrieri MP; Spire B
    J Pain Symptom Manage; 2007 Oct; 34(4):413-21. PubMed ID: 17616331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study.
    Posthouwer D; Yee TT; Makris M; Fischer K; Griffioen A; Van Veen JJ; Mauser-Bunschoten EP
    J Thromb Haemost; 2007 Aug; 5(8):1624-9. PubMed ID: 17663735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K; VAN Erpecum KJ; DE Knegt RJ
    J Thromb Haemost; 2007 Jan; 5(1):25-30. PubMed ID: 17239163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The neuropsychiatric side effects of the interferon therapy in patients with chronic hepatitis B and C].
    Lapiński TW; Prokopowicz D
    Pol Merkur Lekarski; 1999 Jul; 7(37):8-11. PubMed ID: 10522402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship between emotional distress, cognitive performance and health - related quality of life in patients with hepatitis C prior to antiviral treatment].
    Rothenhäusler HB; Scherr M; Putz-Bankuti C; Kapper A; Stepan A; Baranyi A; Haas-Krammer A; Haas B; Stauber R
    Fortschr Neurol Psychiatr; 2009 Aug; 77(8):457-63. PubMed ID: 19676008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living with hepatitis C and treatment: the personal experiences of patients.
    Sgorbini M; O'Brien L; Jackson D
    J Clin Nurs; 2009 Aug; 18(16):2282-91. PubMed ID: 19583661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
    Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
    Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifn/Rbv treatment induced anemia and its correction with epoetin alpha in patients with hepatitis C.
    Sharvadze L; Tsertsvadze T; Gochitashvili N; Kakabadze T; Dolmazashvili E
    Georgian Med News; 2006 Aug; (137):62-5. PubMed ID: 16980747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of successful HCV treatment in patients with inherited bleeding disorders, assessed by liver stiffness measurements.
    Fransen van de Putte DE; Fischer K; de Knegt RJ; Posthouwer D; van Erpecum KJ; Biesma DH; Mauser-Bunschoten EP
    Haemophilia; 2012 May; 18(3):e266-72. PubMed ID: 22103568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Side effects of interferon therapy for chronic hepatitis C].
    Arase Y
    Nihon Rinsho; 2006 Jul; 64(7):1363-7. PubMed ID: 16838657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.
    Wirth S; Lang T; Gehring S; Gerner P
    Hepatology; 2002 Nov; 36(5):1280-4. PubMed ID: 12395341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.
    Ancel D; Amiot X; Chaslin-Ferbus D; Hagege I; Garioud A; Girot R; Pol S; Grange JD
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):726-9. PubMed ID: 19404206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.